MENU
PALI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Palisade Bio (PALI) Earnings Date & Reports
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier... Show more
A.I. Advisor
published Earnings
PALI is expected to report earnings to rise 20.00% to -5 cents per share on November 16
Q3'26
Est.
$-0.06
Q1'26
Beat
by $0.39
Q4'25
Beat
by $0.23
Q3'25
Beat
by $0.17
Q2'25
Beat
by $0.21
The last earnings report on May 12 showed earnings per share of -5 cents, beating the estimate of -43 cents. With 1.55M shares outstanding, the current market capitalization sits at 358.54M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds
Industry Biotechnology
Profile
Details
Industry
N/A
Address
4600 South Syracuse Street
Phone
+1 858 704-4900
Employees
14
Web
https://www.palisadebio.com